Lancet neurology

• Latest
• Best
• Search…

• Lancet neurology · May 2015

  Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.

  Preclinical data suggest that the loop-diuretic bumetanide might be an effective treatment for neonatal seizures. We aimed to assess dose and feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizures. ⋯ European Community's Seventh Framework Programme.

  read more… or not…

• Lancet neurology · May 2015

  Comment

  Multiple sclerosis drugs: how much bang for the buck?

  no abstract available

  read on… mark as read…

• Lancet neurology · May 2015

  Comment

  Tackling diagnostic delays in ALS.

  no abstract available

  explore more… or not…

• Lancet neurology · May 2015

  Comment

  Brain CT signs and the effect of alteplase after stroke.

  no abstract available

  read on… mark as read…

• Lancet neurology · May 2015

  Apathy: who cares?

  no abstract available

  explore further… or not…